{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T20:29:19Z","timestamp":1776198559021,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1097\/yco.0b013e3282ab9952","type":"journal-article","created":{"date-parts":[[2007,8,6]],"date-time":"2007-08-06T07:04:45Z","timestamp":1186383885000},"page":"461-466","source":"Crossref","is-referenced-by-count":81,"title":["Psychotropic medication for behaviour problems in people with intellectual disability: a review of the current literature"],"prefix":"10.1097","volume":"20","author":[{"given":"Shoumitro","family":"Deb","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma L","family":"Unwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210206","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ridd.2004.03.004","article-title":"Psychotropic medication in adults with mental retardation: prevalence, and prescription practices","volume":"25","author":"Holden","year":"2004","journal-title":"Res Dev Disabil"},{"key":"R2-7-20210206","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1046\/j.1365-2788.2001.00374.x","article-title":"Mental disorder in adults with intellectual disability. 1: Prevalence of functional psychiatric illness among a community-based population aged between 16\u201364 years","volume":"45","author":"Deb","year":"2001","journal-title":"J Intellect Disabil Res"},{"key":"R5-7-20210206","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00213-004-2093-2","article-title":"Short and long-term efficacy and safety of risperidone in adults with disruptive behaviour disorders","volume":"179","author":"Gagiano","year":"2005","journal-title":"Psychopharmacology"},{"key":"R6-7-20210206","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","article-title":"Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders","volume":"114","author":"Shea","year":"2004","journal-title":"Pediatrics"},{"key":"R7-7-20210206","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1176\/appi.ajp.159.8.1337","article-title":"Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviours in children with subaverage intelligence","volume":"159","author":"Aman","year":"2002","journal-title":"Am J Psychiatry"},{"key":"R8-7-20210206","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioural problems.","volume":"347","year":"2002","journal-title":"New Engl J Med"},{"key":"R9-7-20210206","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1097\/00004583-200209000-00002","article-title":"Effects of risperidone on conduct and disruptive behaviour disorders in children with subaverage IQs","volume":"41","author":"Snyder","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R10-7-20210206","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1176\/appi.ajp.162.7.1361","article-title":"Risperidone treatment of autistic disorder: longer-term benefits and blinded discontinuation after 6 months.","volume":"162","year":"2005","journal-title":"Am J Psychiatry"},{"key":"R11-7-20210206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1542\/peds.110.3.e34","article-title":"Long-term safety and efficacy of risperidone for the treatment of disruptive behaviour disorders in children with subaverage IQs","volume":"110","author":"Turgay","year":"2002","journal-title":"Pediatrics"},{"key":"R12-7-20210206","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1176\/appi.ajp.161.4.677","article-title":"Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ","volume":"161","author":"Findling","year":"2004","journal-title":"Am J Psychiatry"},{"key":"R13-7-20210206","first-page":"122","article-title":"Efficacy and tolerability of quetiapine in patients with mental retardation and behaviour disorders","volume":"13","author":"La Malfa","year":"2003","journal-title":"Nuova Riv Neurol"},{"key":"R14-7-20210206","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2788.2004.00626.x","article-title":"The use of clozapine in adults with intellectual disability","volume":"48","author":"Thalayasingam","year":"2004","journal-title":"J Intellect Disabil Res"},{"key":"R15-7-20210206","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.4088\/JCP.v64n1018","article-title":"Olanzapine for self-injurious, aggressive, and disruptive behaviors in intellectually disabled adults: a retrospective, open-label, naturalistic trial","volume":"64","author":"Janowsky","year":"2003","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"R16-7-20210206","first-page":"CD000377","article-title":"Antipsychotic medication for challenging behaviour in people with learning disability.","author":"Brylewski","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"R17-7-20210206","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ridd.2004.07.001","article-title":"The use of risperidone among individuals with mental retardation: clinically supported or not?","volume":"26","author":"Singh","year":"2005","journal-title":"Res Dev Disabil"},{"key":"R19-7-20210206","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1017\/S146114570400481X","article-title":"Serotonergic antidepressant effects on aggressive, self-injurious and destructive\/ disruptive behaviours in intellectually disabled adults: a retrospective, open-label, naturalistic trial","volume":"8","author":"Janowsky","year":"2005","journal-title":"Int J Neuropsychopharmacol"},{"key":"R20-7-20210206","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1352\/0895-8017(1998)102<0427:PTOAAS>2.0.CO;2","article-title":"Paroxetine treatment of aggression and self-injury in persons with mental retardation","volume":"102","author":"Davanzo","year":"1998","journal-title":"Am J Ment Retard"},{"key":"R21-7-20210206","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1046\/j.1365-2788.1998.00144.x","article-title":"Selective serotonin re-uptake inhibitors for the treatment of perseverative and maladaptive behaviours of people with intellectual disability","volume":"42","author":"Branford","year":"1998","journal-title":"J Intellect Disabil Res"},{"key":"R22-7-20210206","first-page":"299","article-title":"Clomipramine treatment for stereotype and related repetitive movement disorders associated with mental retardation","volume":"100","author":"Lewis","year":"1995","journal-title":"Am J Ment Retard"},{"key":"R23-7-20210206","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-2007-979593","article-title":"Effects of fluoxetine on aggressive behavior of adult inpatients with mental retardation and epilepsy","volume":"28","author":"Troisi","year":"1995","journal-title":"Pharmacopsychiatry"},{"key":"R24-7-20210206","first-page":"360","article-title":"Diagnosis and fluoxetine treatment of compulsive behavior disorder of adults with mental retardation","volume":"98","author":"Bodfish","year":"1993","journal-title":"Am J Ment Retard"},{"key":"R25-7-20210206","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/00004583-199207000-00024","article-title":"Fluoxetine treatment of children and adults with autistic disorder and mental retardation","volume":"31","author":"Cook","year":"1992","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"R26-7-20210206","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004714-199202000-00005","article-title":"Effect of fluoxetine on self-injurious behavior in the developmentally disabled: A preliminary study","volume":"12","author":"Markowitz","year":"1992","journal-title":"J Clin Psychopharmacol"},{"key":"R27-7-20210206","first-page":"3","article-title":"Fluvoxamine and mental retardation: Clinical use","volume":"10","author":"La Malfa","year":"1997","journal-title":"Ital J Intellect Impairment"},{"key":"R29-7-20210206","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/01.jcp.0000088906.24613.76","article-title":"Effects of topiramate on aggressive, self-injurious, and disruptive\/destructive behaviours in the intellectually disabled: An open-label retrospective study","volume":"23","author":"Janowsky","year":"2003","journal-title":"J Clin Psychopharmacol"},{"key":"R30-7-20210206","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1468-3148.2001.00063.x","article-title":"Cyclothymia or unstable mood disorder? A systematic treatment evaluation with valproic acid","volume":"14","author":"Verhoeven","year":"2001","journal-title":"J Appl Res Intellect Disabil"},{"key":"R32-7-20210206","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1001\/archpsyc.1995.03950210060011","article-title":"Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults: Double-blind placebo-controlled studies","volume":"52","author":"Willemsen-Swinkels","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"R33-7-20210206","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/mrdd.20031","article-title":"Self-injurious behavior and the efficacy of naltrexone: a quantitative synthesis","volume":"10","author":"Symons","year":"2004","journal-title":"Ment Retard Dev Disabil Res Rev"},{"key":"R34-7-20210206","first-page":"22","article-title":"Buspirone treatment of aggression and self-injury in autistic and nonautistic persons with severe mental retardation","volume":"90","author":"King","year":"1996","journal-title":"Dev Brain Dysfunction"},{"key":"R35-7-20210206","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/j.1440-1665.2004.02130.x","article-title":"Psychostimulant treatment of adults with mental retardation and attention-deficit hyperactivity disorder","volume":"12","author":"Jou","year":"2004","journal-title":"Australas Psychiatry"},{"key":"R36-7-20210206","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.genhosppsych.2005.02.005","article-title":"Treatment of psychomotor agitation and self-injurious behaviour with estrogen and progesterone treatment in a patient with Sanfilippo syndrome","volume":"27","author":"Kushner","year":"2005","journal-title":"Gen Hosp Psychiatry"},{"key":"R37-7-20210206","first-page":"103","article-title":"Effects of serum zinc supplementation on pica behaviour of persons with mental retardation","volume":"95","author":"Lofts","year":"1990","journal-title":"Am J Ment Retard"},{"key":"R38-7-20210206","first-page":"233","article-title":"A meta analysis of intervention research with problem behaviour: treatment validity and standards of practice","volume":"96","author":"Scotti","year":"1991","journal-title":"Am J Ment Retard"},{"key":"R39-7-20210206","first-page":"387","article-title":"Meta-analytic study on treatment effectiveness for problem behaviors with individuals who have mental retardation","volume":"101","author":"Didden","year":"1997","journal-title":"Am J Ment Retard"},{"key":"R41-7-20210206","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0005-7916(91)90017-Y","article-title":"Social skills training in adults with psychiatric populations: a meta analysis","volume":"22","author":"Corrigan","year":"1991","journal-title":"J Behav Ther Exp Psychiatry"}],"container-title":["Current Opinion in Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/YCO.0b013e3282ab9952","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T07:42:22Z","timestamp":1620978142000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001504-200709000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/yco.0b013e3282ab9952","relation":{},"ISSN":["0951-7367"],"issn-type":[{"value":"0951-7367","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}